Pharos’ AI-Designed Leukemia Drug Earns Orphan Designation in Europe
Pharos iBio, a South Korea-based biotech specializing in AI-driven drug discovery, announced that its lead investigational asset PHI-101,…
KOSDAQ
2 개의 기사가 있습니다.
Orum Therapeutics Sets Goal of USD 70 Million by 2026
Orum Therapeutics, a biotechnology company preparing for its KOSDAQ listing, announced its goal to achieve sales of KRW…